Phreesia Inc. (PHR) PT Lowered to $37 at Citi
Get Alerts PHR Hot Sheet
Price: $12.00 +0.33%
Rating Summary:
16 Buy, 8 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Rating Summary:
16 Buy, 8 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 20
Join SI Premium – FREE
Citi analyst Daniel Grosslight lowered the price target on Phreesia Inc. (NYSE: PHR) to $37.00 (from $40.00) while maintaining a Buy rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- HCA Healthcare Inc (HCA) PT Lowered to $425 at JPMorgan
- Eclat Textile Co Ltd (1476:TT) PT Lowered to NT$547 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share